The results of this second phase will provide the data needed to submit a large effectiveness trial to the National Institutes of Health, National Cancer Institute. This will be a partnership between Mayo Clinic, ASU, and Udaya in the hopes of providing a non pharmacological complementary approach to symptom management in MPN patients. This study is supported by philanthropic funds from an MPN patient, and is not linked to any pharmaceutical company or drug.
Survey of Integrative Medicine in Myeloprolifertive Neoplasms
Drs. Ruben Mesa and Krisstina Gowin, Mayo Clinic AZ
To complete and submit click on this link: